Vertex Pharmaceuticals Inc (VRTX)
471.12
-4.86
(-1.02%)
USD |
NASDAQ |
Nov 01, 16:00
471.00
-0.12
(-0.03%)
After-Hours: 20:00
Vertex Pharmaceuticals Total Liabilities (Quarterly): 5.357B for June 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 5.357B |
| March 31, 2024 | 5.371B |
| December 31, 2023 | 5.150B |
| September 30, 2023 | 5.213B |
| June 30, 2023 | 4.879B |
| March 31, 2023 | 4.542B |
| December 31, 2022 | 4.238B |
| September 30, 2022 | 3.677B |
| June 30, 2022 | 3.649B |
| March 31, 2022 | 3.349B |
| December 31, 2021 | 3.332B |
| September 30, 2021 | 3.088B |
| June 30, 2021 | 3.025B |
| March 31, 2021 | 3.135B |
| December 31, 2020 | 3.065B |
| September 30, 2020 | 3.168B |
| June 30, 2020 | 2.697B |
| March 31, 2020 | 2.432B |
| December 31, 2019 | 2.233B |
| September 30, 2019 | 2.261B |
| June 30, 2019 | 1.964B |
| March 31, 2019 | 1.820B |
| December 31, 2018 | 1.811B |
| September 30, 2018 | 1.686B |
| June 30, 2018 | 1.621B |
| Date | Value |
|---|---|
| March 31, 2018 | 1.522B |
| December 31, 2017 | 1.504B |
| September 30, 2017 | 1.395B |
| June 30, 2017 | 1.418B |
| March 31, 2017 | 1.264B |
| December 31, 2016 | 1.559B |
| September 30, 2016 | 1.401B |
| June 30, 2016 | 1.380B |
| March 31, 2016 | 1.372B |
| December 31, 2015 | 1.405B |
| September 30, 2015 | 1.357B |
| June 30, 2015 | 1.326B |
| March 31, 2015 | 1.168B |
| December 31, 2014 | 1.238B |
| September 30, 2014 | 1.250B |
| June 30, 2014 | 945.55M |
| March 31, 2014 | 966.23M |
| December 31, 2013 | 962.64M |
| September 30, 2013 | 1.136B |
| June 30, 2013 | 1.075B |
| March 31, 2013 | 1.454B |
| December 31, 2012 | 1.563B |
| September 30, 2012 | 1.454B |
| June 30, 2012 | 1.361B |
| March 31, 2012 | 1.240B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
2.233B
Minimum
Dec 2019
5.371B
Maximum
Mar 2024
3.768B
Average
3.349B
Median
Mar 2022
Total Liabilities (Quarterly) Benchmarks
| Eli Lilly and Co | 61.29B |
| Bristol-Myers Squibb Co | 76.47B |
| Regeneron Pharmaceuticals Inc | 8.116B |
| Sarepta Therapeutics Inc | 2.347B |
| Moderna Inc | 3.968B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 20.13B |
| Shareholders Equity (Quarterly) | 14.77B |
| Current Ratio | 2.521 |